HEPATITIS C AND IRON OVER LOAD
Abstract
Hepatitis C is a liver disease caused by the hepatitis C virus: the virus can cause both acute and chronic hepatitis infection. Patients with chronic hepatitis C virus (HCV) infection appear to have an excellent chance of responding to 6 months of standard therapy with interferon (IFN) and frequently develop systemic iron overload, which exacerbates morbidity. The iron excess in hepatitis C may be due to hereditary hemochromatosis, hematologic diseases, multiple transfusions, porphyria cutanea tarda and chronic alcohol abuse. Different mechanisms proposed to explain the relation between HCV infection and hepatic iron overload. Some revealed that hepatic iron accumulation results from release of iron from damaged liver cells. Consumption of coffee, tea also reduces iron absorption and thereby decrease iron overload in Liver and thereby reduces the oxidative stress of iron overload in liver. The global scenario of this problem has been discussed in the article.
Keywords:
Iron, HCV, Tea, Liver, IFN, PhlebotomyDownloads
References
Alexander, J., Tung, B. Y., Croghan, A., Kowdley, K. V. (2007) Effect of iron depletion on serum markers of
fibrogenesis, oxidative stress, serum liver enzymes in chronic hepatitis C: results of a pilot study. Liver Int. 27, pp. 268–273.
Andant, C., Lamoril, J., Edery, J. et al. (1996). Hepatic iron concentration (HIC) and serum iron parameters in patients with chronic hepatitis C, Hepatology. 26, pp. 478A.
Anghileri, L. J. and Thouvenot, P. (2000). Natural polyphenols-iron interaction its biological importance,
Biol Trace Element Res. 73, pp.251.
Barbaro, G., Di Lorenzo, G., Ribersani, M., Soldini, M., Giancaspro, G., Bellomo, G., Belloni, G., Grisorio, B., Barbarini, G. (1999). Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype, J. Hepatol. 30, pp.774–782.
Carlo, C., Daniela, P., Giancarlo, C. (2003). Iron depletion and response to interferon in chronic hepatitis C, Hepatogastroenterology, 50, pp.1467–1471.
Casaril, M., Stanzial, A.M., Tognella, P., Pantalena, M., Capra, F., Colombari, R., Corrocher, R. (2000). Role of iron load on fibrogenesis in chronic hepatitis C, Hepatogastroenterology, 47, pp.220–225.
Darwich, E., To-Figueras, J., Molina-Lopez, R. A., Deulofeu, R., Olbina, G., Westerman, M., Sanchez-Tapias, J. M., Munoz-Santos, C., Herrero, C. (2013). Increased serum hepcidin levels in patients with porphyria cutanea tarda, J. Eur. Acad. Dermatol. Venereol., 27, pp.68–74.
Deugnier, Y. M., Turlin, B., Powell, L. W. et al. (1993). Differentiation between hetero zygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases, Hepatology, 17, pp. 30-4.
Di Bisceglie, A. M., Bonkovsky, H. L., Chopra, S., Flamm, S., Reddy, R. K., Grace, N., Killenberg, P., Hunt, C., Tamburro, C., Tavill, A. S., et al.(2000). Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded
to interferon: A multicenter, prospective, randomized, controlled trial, Hepatology, 32, pp.135–138.
Di Bisceglie, A. M., Axiotis, C. A., Hoofnagle, J. H., Bacon, B. R. (1992). Measurements of iron status in patients with chronic hepatitis, Gastroenterology, 102, pp. 2108-13.
Di Marco, V., Lo Iacono, O., Almasio, P. et al. (1997). Longterm efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C, Blood, 90, pp.2207-12.
Disler, P. B., Lynch, S. R. and Chalton, R. W., (1975). The effect of tea on iron absorption, Gut, 16, pp.193.
D'Souza R.F., Feakins R., Mears L., Sabin C. A., Foster, G. R. (2005). Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C, Aliment. Pharmacol. Ther. 21, pp.519–524.
Fargion, S., Fracanzani, A. L., Sampietro, M. et al. (1997). Liver iron influences the response to interferon alpha therapy in chronic hepatitis C, Eur. J. Gastroenterol. Hepatol, 9, pp. 497-503.
Fontana, R. J., Israel, J., LeClair, P., Banner, B. F., Tortorelli, K., Grace, N., Levine, R. A., Fiarman, G., Thiim, M., Tavill, A. S., et al. (2000). Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial,
Hepatology, 31, pp.730–736.
Fujita, N., Horiike, S., Sugimoto, R., Tanaka, H., Iwasa, M., Kobayashi, Y., Hasegawa, K., Ma, N., Kawanishi, S., Adachi, Y., et al. (2007). Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients, Free Radic. Biol. Med. 42, pp.353–362.
Fujita, N., Sugimoto, R., Urawa, N., Tanaka, H., Konishi, M., Kobayashi, Y., Iwasa, M., Watanabe, S., Kaito, M. (2007). Influence of phlebotomy on iron-related gene expression levels in the livers of patients with chronic hepatitis C, J. Gastroenterol. 42, pp.326–327.
Furutani, T., Hino, K., Okuda, M., Gondo, T., Nishina, S., Kitase, A., Korenaga, M., Xiao, S.Y., Weinman, S. A., Lemon, S. M., et al.(2006). Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein, Gastroenterology, 130, pp.2087–2098.
Ganne-Carrie, N., Christidis, C., Chastang, C. et al. (2000). Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study, Gut, 46, pp. 277-82.
Guyader, D., Boucher, E., Andre, P., Even, C., Cottereau, J., Bianchi, A., Gasser, P., Mendler, M. H., Deugnier, Y., Brissot, P. (1999). A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferon, Am J Gastroenterol, 94,
pp.1696–1698.
Haque, S., Chandra, B., Gerber, M. A., Lok, A. S. (1996). Iron overload in patients with chronic hepatitis C: a clinicopathologic study, Hum. Pathol, 27, pp.1277-81.
Herrera, J. L. (1999). Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy, Am. J. Gastroenterol. 94, pp.3571–3575.
Hezode, C., Cazeneuve, C., Coue, O. et al. (1999). Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions, J. Hepatol. 31, pp. 979-84.
Hofer, H., Osterreicher, C., Jessner, W., Penz, M., Steindl-Munda,P.,Wrba,F.,etal.(2004).Hepaticiron concentration does not predict response to standard and pegylated-IFN/ribavirintherapyinpatientswith chronic hepatitis C, J Hepatol, 40, pp.1018–1022.
Honjo, S., Kono, S., Coleman, M. P., Shinchi, K., Sakurai, Y. etal.(2001).Coffeeconsumptionandserum aminotransferases in middle-aged Japanese men, J Clin Epidemiol, 54, pp. 823-829.
Imai, K., Nakachi, K. (1995). Cross sectional study of effects ofdrinkinggreenteaoncardiovascularandliver diseases, BMJ, 310, pp.693-696.
Inoue, M., Kurahashi, N., Iwasaki, M., Shimazu, T., Tanaka, Y., Mizokami, M., Tsugane, S. (2009). Effect of Coffee and Green Tea Consumption on the Risk of Liver Cancer: Cohort Analysis by Hepatitis Virus Infection Status.CancerEpidemiology,Biomarkersand Prevention,18(6), pp. 1744-1753.
Isom, H. C., McDevitt, E. I., Moon, M.S. (2009). Elevated hepatic iron: a confounding factor in chronic hepatitis C, Biochim Biophys Acta, 1790(7), pp.650-62.
Ivonete, S. S., Silva, Renata, M. Perez, Pedro V. Oliveira, Maria, Inês Cantagalo, Elizabete Dantas, Cristina, Sisti, Cláudio,Figueiredo-Mendes,Valeria,P.Lanzoni, Antonio, E.B. Silva, Maria, Lucia, G. Ferraz, (2005). Iron Overload in Patients with Chronic Hepatitis C Virus Infection:ClinicalandHistologicalStudy,J Gastroenterol Hepatol, 20(2), pp.243-248.
Iwasa, M., Kaito, M., Ikoma, J., Kobayashi, Y., Tanaka, Y., Higuchi, K., Takeuchi, K., Iwata, K., Watanabe, S., Adachi, Y. (2002). Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients, Hepatogastroenterology, 49, pp.529–531.
Kaito, M., Iwasa, M., Kobayashi, Y., Fujita, N., Tanaka, H., Gabazza, E. C., et al. (2006) Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stressinpatientswithchronichepatitisC,J Gastroenterol, 41, pp.921–922.
Kato, J., Kobune, M., Nakamura, T., Kuroiwa, G., Takada, K.,Takimoto,R.,etal.(2001).Normalizationof elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet, Cancer Res, 61, pp.8697–8702.
Kato, J., Miyanishi, K., Kobune, M., Nakamura, T., Takada, K., Takimoto, R., et al. (2007). Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C, J Gastroenterol, 42, pp.830–836.
Kimura,F.,Hayashi,H.,Yano,M.,Yoshioka,K., Matsumura, T., Fukuda, T., et al. (2005). Additional effect of low iron diet on iron reduction therapy by phlebotomyforchronichepatitisC,Hepato-gastroenterology, 52, pp.563–566.
Kralj, D., Jukić, L. V., Stojsavljević, S., Duvnjak, M., Smolić, M., & Čurčić, I. B. (2016). Hepatitis C Virus, Insulin Resistance, and Steatosis, Journal of Clinical and Translational Hepatology, 4(1), pp. 66–75. Lauer GM, Walker BD. (2001). Hepatitis C virus infection, N Engl J Med, 345, pp.41–52.
Lecube,A.,Hernández,C.,Simó,R.(2009).Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload, 25(5), pp. 403-10.
Martinelli, A. L., Ramalho, L. N., Zucoloto, S. (2004). Hepatic stellate cells in hepatitis C patients: relationship with liver iron deposits and severity of liver disease, J. Gastroenterol. Hepatol,19, pp. 91–98.
Martinelli, A. L., Franco, R. F., Villanova, M. G. et al. (2000a). Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?, Acta Haematol, 102, pp. 152-6.
Martinelli, A. L., Zago, M. A., Roselino, A. M. et al. (2000). PorphyriacutaneatardainBrazilianpatients: association with hemochromatosis C282Ymutation and hepatitis C virus infection, 95, pp.3516-21.
Miura, K., Taura, K., Kodama, Y., Schnabl, B., Brenner, D. A. (2008). Hepatitis C virus-induced oxidative stress suppresseshepcidinexpressionthroughincreased histonedeacetylaseactivity,Hepatology,48, pp.1420–1429.
Nelson, J. E., Klintworth, H., Kowdley, K.V. (2012). Iron metabolism in Nonalcoholic Fatty Liver Disease, Curr Gastroenterol Rep, 14(1), pp.8-16.
Nishina, S., Korenaga, M., Hidaka, I., Shinozaki, A., Sakai, A., Gondo, T., Tabuchi, M., Kishi, F., Hino, K. (2010). Hepatitis C virus protein and iron overload induce hepatic steatosis through the unfolded protein response in mice, Liver Int, 30, pp.683–692
Pianko, S., McHutchison, J. G., Gordon, S. C., Heaton, S., Goodman, Z. D., Patel, K., et al. (2002) Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCVinfection, J Interf Cytokine Res, 22, pp.483–489.
Poddar, S. (2006). Hereditary Hemachromatosis – special reference to Indian scenario, Int. Jou. Hum. Genetics, 6(1), pp. 73-79.
Poddar, S. (2004). Dietary intervention with iron and black tea infusion in reducing cytotoxicity of arsenic, Indian Journal of Experimental Biology, 42, pp. 900-903.
Poynard,T.,Ratziu,V.,Charlote,F.,Goodman,Z., McHutchison, J., Albrecht, J. (2001). Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C, J. Hepatol. 34, pp.730-9.
Roeckel, I. E. (2000). Commentary: Iron metabolism in hepatitis C infection, Ann Clin Lab Sci., 30(2), pp.163-5.
Sasaki, Y., Ohfuji, S., Fukushima, W., Tamori, A., Enomoto, M.,etal.(2013).EffectofCaffeine-Containing Beverage Consumptionon Serum Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C Virus Infection: AHospital-Based Cohort Study, PLOS ONE, 8(12), pp. e83382.
Sebastiani, G., Vario, A., Ferrari, A., Pistis, R., Noventa, F., Alberti, A. (2006). Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C, J. Viral. Hepat., 13, pp.199–205.
Sumida, Y., Kanemasa, K., Fukumoto, K., Yoshida, N., Sakai, K. (2007). Hepatic iron accumulation may be associated with in sulinresistanceinpatientswith chronic hepatitis C, Hepatol. Res., 37, pp. 932–940.
Tanaka,K.,Tokunaga,S.,Kono,S.,Tokudome,S., Akamatsu, T. et al. (1998). Coffee consumption and decreased serumgamma-glutamyl transferase and amino transferase activities among male alcohol drinkers, Int J Epidemiol, 27, pp.438-443.
Vagu, C., Sultana, C., and Ruta, S. (2013). Serum Iron Markers in Patients With Chronic Hepatitis C Infection, HepatitisMonthly,13(10),e13136. http://doi.org/10.5812/hepatmon.13136Van,
Thiel D. H., Friedlander, L., Fagiuoli, S., Wright, H. I., Irish, W., Gavaler, J. S. (1994). Response to interferon alpha therapy is influenced by the iron content of the liver, J. Hepatol, 20, pp. 410-15.
Yano, M., Hayashi, H., Yoshioka, K., Kohgo, Y., Saito, H., Niitsu, Y., Kato, J., Iino, S., Yotsuyanagi, H., Kobayashi, Y., et al. (2004). Asignificant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapyforchronichepatitisC:A multicenter, prospective, randomized, controlled trial in Japan, J. Gastroenterol, 39, pp.570–574.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Malaysian Journal of Medical Research (MJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
